Ra Pharmaceuticals Inc Forecast and Stock Analysis
Technical RARX stock analysis for April 24, 2019.
Ra Pharmaceuticals Inc fell by -1.41% in the last day from $21.96 to $21.65 The price has fallen in 8 of the last 10 days and is down by -8.46% for this period. Volume has increased in the last day by 109 166 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 414 662 shares bought and sold for approximately $8.98 million.
Close price at the end of the last trading day (Wednesday, 24th Apr 2019) of the RARX stock was $21.65. This is 1.41% less than the trading day before Tuesday, 23rd Apr 2019.
During day the stock fluctuated 4.31% from a day low at $21.35 to a day high of $22.27.
30 day high of the RARX stock price was $24.49 and low was $20.19.
90 day high was $27.68 and low was $18.06.
52 week high for the Ra Pharmaceuticals Inc - $27.68 and low - $5.64.
Ra Pharmaceuticals Inc lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 14.48% during the next 3 months and, with 90% probability hold a price between $21.97 and $33.01 at the end of this period.
There are few to none technical positive signals at the moment. Ra Pharmaceuticals Inc holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $23.40. On a fall, the stock will find some support from the short-term average at $21.57. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. A sales signal was issued from a pivot top point on Tuesday April 23, 2019, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Relative Strength Index (RSI)
RSI14 is 45 and the stock is currently not being overbought or oversold
Support & Resistance
Ra Pharmaceuticals Inc finds support from accumulated volume at $20.88.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.92 between high and low, or 4.31%. For the last week, the stock has had a daily average volatility of 5.83%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Evaluation: Sell Candidate
The Ra Pharmaceuticals Inc stock holds several negative signals and despite the positive trend we believe Ra Pharmaceuticals Inc will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|RARX $21.65 ($-0.31 -1.41%)|
RARX is down $0.31 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for RARX based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the RARX analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us